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Control over the number ofmtDNAmolecules per cell
appears to be tightly regulated, but the mechanisms
involved are largely unknown. Reversible alterations
in the amount of mtDNA occur in response to stress
suggesting that control over the amount of mtDNA
is involved in stress-related diseases including major
depressive disorder (MDD). Using low-coverage
sequence data from 10,442 Chinese women to
compute the normalized numbers of reads mapping
to the mitochondrial genome as a proxy for the
amount of mtDNA, we identified two loci that
contribute to mtDNA levels: one within the TFAM
gene on chromosome 10 (rs11006126, p value =
8.73 3 1028, variance explained = 1.90%) and one
over the CDK6 gene on chromosome 7 (rs445,
p value = 6.03 3 1016, variance explained =
0.50%). Both loci replicated in an independent
cohort. CDK6 is thus a new molecule involved in
the control of mtDNA. We identify increased rates
of heteroplasmy in women with MDD, and show
from an experimental paradigm using mice that the
increase is likely due to stress. Furthermore, at least
one heteroplasmic variant is significantly associated
with changes in the amount of mtDNA (position 513,
p value = 3.27 3 109, variance explained = 0.48%)
suggesting site-specific heteroplasmy as a possible
link between stress and increase in amount of
mtDNA. These findings indicate the involvement of
mitochondrial genome copy number and sequence
in an organism’s response to stress.
INTRODUCTION
The number ofmtDNAmolecules appears to be tightly regulated,
as inferred from the constant amount of mtDNA per mitochon-
drion in different cells in the presence of marked variation in
the number of mitochondria between cell types [1]. The mecha-3170 Current Biology 25, 3170–3177, December 21, 2015 ª2015 Thenisms involved are largely unknown [2, 3]. One of the compo-
nents of the mtDNA replication machinery, mitochondrial
transcription factor A (TFAM), appears to be a key transcription
factor controlling the amount of mtDNA [4], but it is still not
known how that signal is used by cells to count the amount of
mtDNA that they require. The observation that the number of
mitochondria predicts cell division better than other measures
such as cell volume or cell size [5] suggests replication of mtDNA
and mitochondrial biogenesis, while autonomous, may be regu-
lated by cell-cycle machinery and vice versa.
We recently observed that the amount of mtDNA alters in
response to external stress: there was significantly more mtDNA
in the saliva and blood of people with major depression than in
controls [6]. Chronic stress also altered the amount of mtDNA in
mouse tissues, and, at least in part, was restored to pre-stress
levels following cessation of stress [6]. Changes in cellular
composition could not account for these observations [6], sug-
gesting that themtDNAalterations reflected changeswithin cells,
and corticosteroid signaling down the hypothalamic-pituitary
axis may be involved in causing these changes since injection
of corticosterone alone can recapitulate effects of chronic stress.
These findings raised questions as to what contributes to
changes in the amount of mtDNA, how that is related to major
depressive disorder, and what are the consequences for a cell
of maintaining a high turnover of mtDNA molecules, which
have relatively high mutation rates. We set out to use genotypes
and measures of mtDNA levels from whole-genome low-
coverage sequencing on 10,442 Han Chinese women recruited
in the CONVERGE (China, Oxford, and Virginia Commonwealth
University Experimental Research on Genetic Epidemiology)
Consortium of Major Depressive Disorder (MDD). Using this
dataset, we set out to perform the first genome-wide association
study (GWAS) on mtDNA levels to discover what might be
involved in the molecular pathways controlling mtDNA levels.
We further ask whether variation in mtDNA sequences contrib-
utes to variations in the amount of mtDNA andwhether such vari-
ation is related to MDD.
RESULTS
CONVERGE obtained sequence from Chinese women with a
mean coverage of 1.73 of the nuclear genome [7]. For this study,Authors
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Table 1. Replication of Association with Amount of mtDNA at Top
GWAS SNPs
Cohort SNP Beta SE p
Converge rs445 0.119 0.015 4.57E-16
ALSPAC rs445 0.110 0.057 2.14E-02
Joint rs445 0.118 0.014 3.84E-17
Converge rs11006126 0.195 0.018 1.17E-27
ALSPAC rs11006126 0.179 0.047 1.53E-04
Joint rs11006126 0.193 0.017 1.08E-30
This table shows the effect size (Beta) and its SE and p values (p) from
linear regression for association between the two top SNPs (SNP) in
CDK6 (rs445) and TFAM (rs11006127) genes in three cohorts (Cohort):
our study, CONVERGE; the ALSPAC cohort in UK10K; and a joint cohort
containing samples from both CONVERGE and ALSPAC. All associations
were significant and the directions of effect at both SNPs in both cohorts
are the same. (Note: Linear regression was used for the replication and
joint analysis as we did not have whole-genome SNP information from
the ALSPAC cohort for a linear mixed-model approach using a GRM,
as we did in CONVERGE. The p values for SNP associations with amount
of mtDNA in CONVERGE were recalculated with linear regression for
comparability with replication and joint analyses.) See also Table S1.we used sequences from 5,224 women with MDD and 5,218
controls, and imputed allele dosages at 6,242,619 SNPs across
the nuclear genome (details on imputation methodology and ge-
notype quality are given in [7]). We began by determining that the
amount of mtDNA, defined as the number of reads mapping to
the mitochondrial genome over read coverage of the nuclear
genome, controlled for age of subject and sequencing batch
(Experimental Procedures), is a heritable trait, with an estimated
SNP-based heritability [8] of 15.6% (SE = 5.1%; p value = 1.063
103). We then mapped variation in the amount of mtDNA as
a quantitative trait and identified two loci that exceeded
genome-wide significance (genomic control lambda [l] =
1.017; Figure 1A). One locus is within the TFAM gene on chromo-
some 10 (top SNP rs11006126, p value = 8.733 1028, variance
explained by gene = 1.90%, Figure 1B), and the second lies over
the CDK6 gene on chromosome 7 (top SNP rs445, p value =
6.03 3 1016, variance explained by gene = 0.50%, Figure 1C).
The most highly associated SNP (rs11006126) resides in the
30 region of the gene TFAM. The most highly associated SNPs
at the CDK6 locus (rs445) lie in intron 1 of the CDK6 gene.
Both associations replicated in a cohort of 1,753 samples from
the Avon Longitudinal Study of Parent and Children (ALSPAC)
[10], that forms part of the UK10K study [11]. Notably DNA
from this cohort was obtained from blood. Association results
for the top two SNPs (rs445 and rs11006126) in separate
and joint analyses are summarized in Table 1. All SNPs associ-
ated with the amount of mtDNA in the CONVERGE study at
p values <106 are shown in Table S1. Our measure of the
amount of mtDNA from sequencing data is highly correlatedFigure 1. Two Loci Associated with mtDNA
Manhattan plot of genome-wide association for amount of mtDNA (A). Detailed
chromosome 10 at 60.1 Mb (B) and the CDK6 gene on chromosome 7 at position
amount of mtDNA are shown on the left y axis. The horizontal axis gives chromo
bottom panels. Linkage disequilibrium of each SNP with top SNP, shown in l
LocusZoom [9]. See also Figure S1.
3172 Current Biology 25, 3170–3177, December 21, 2015 ª2015 Thewith that from another recently published method [12]. GWAS
using measures from both methods of quantification gave highly
similar results (data not shown).
We next asked whether the mtDNA sequence itself governs
the alterations in mtDNA quantity, and whether cycles of replica-
tion might result in mutations in the mtDNA molecule. The latter
was considered likely given the relatively higher mutation rate of
mtDNA compared to genomic DNA. We therefore set out to
identify variant sites in the 16 Kb mitochondrial genome and to
quantify their frequency both between and within individuals
(coverage of each individual’s mitochondrial genome is approx-
imately 100-fold).
Analysis of variants in mtDNA is subject to a number of poten-
tial confounds, which we took care to avoid. First, we had to
ensure that the sequence variants we obtained were truly in
the mitochondrial and not in the nuclear genome (since the latter
contains partial copies of the former [13]), and also that theywere
not derived from exogenous sources (DNA for this project was
extracted from saliva). After applying stringent quality-control fil-
ters and criteria (Experimental Procedures), 89% of the mito-
chondrial genome was considered sufficiently unique for variant
calling (Figure 2), consistent with previous reports [14]. However,
introgression of some mtDNA into the nuclear genomes of
sequenced subjects might not be present in the reference
genome and would confuse our analysis. Therefore we addition-
ally performed long-range PCR on 72 samples from the
whole cohort (36 cases of MDD, 36 controls) to verify that the
mtDNA variant sites identified through low-coverage sequencing
were not derived from the nuclear genome (Experimental
Procedures).
Second, we needed to identify two forms of variation in the
mitochondrial genome: mtDNA sequence variants can be pre-
sent in all copies (homoplasmy) or be present only in a fraction
of molecules (heteroplasmy). We defined homoplasmic variants
as those sites where there are two alleles present in the cohort,
each supported by more than 90% of sequencing reads in indi-
vidual samples (Experimental Procedures). We identified 1,031
homoplasmic sites occurring at a frequency of greater than
0.1% in our sample, 89% of which were found in 1000 Genomes
Phase 3 whole-genome sequencing data [15]. These included all
known Asian mitochondrial haplogroups (Supplemental Experi-
mental Procedures; Tables S2 and S3). Using linear regression,
no homoplasmic variants were significantly associated with the
amount of mtDNA after correction for multiple testing.
We investigated the association between heteroplasmic sites
and the amount of mtDNA. As we are more likely to detect
heteroplasmy in samples with higher mtDNA coverage (simply
because there are more mtDNA reads), we down-sampled
coverage of the mtDNA in all samples to exactly 50 reads at
each site analyzed. We disregarded sites at which more than
10% of individuals had fewer than 50 reads and therefore could
not be down-sampled, so estimates of heteroplasmy from allviews of two loci associated with amount of mtDNA over the TFAM region on
92.4 Mb (C) are shown. Thelog10 p values of imputed SNPs associated with
somal position in megabases (Mb). Genes within the regions are shown in the
arge purple diamond, is indicated by its color. The plots were drawn using
Authors
Figure 2. Accessibility of mtDNA for Variant Calling
Mean per site read depth across 10,442 samples for all sites on the mtDNA. Reads included in the per site read count have passed the following quality control
criteria: (1) mapping quality >59, (2) both ends of paired-end read map uniquely to the mtDNA reference NC_012920.1, (3) they do not contain mismatches to the
mtDNA reference with total length of 5 bp or above, and (4) base at site in question has base quality of higher than 20. Sites with more than 10% samples with read
depth less than 10 would not be used for calling homoplasmic variants, and sites with more than 10% samples with read depth less than 50 would not be used for
calling heteroplasmic variants. See also Experimental Procedures.remaining sites were based on equal coverage on an adequate
sample size. To be considered a heteroplasmic site in a sample,
we required the presence of two alleles, each supported by two
or more reads, and we additionally required the heteroplasmy to
be present at a frequency greater than 0.1% (present in more
than ten individuals). Using these criteria, we identified 26 heter-
oplasmic sites from low-coverage sequencing.
In order to ensure that we had accurate estimates not just of
the presence but also of the degree of heteroplasmy in an indi-
vidual, we compared the degree of heteroplasmy called from
the 1003 coverage of mtDNA sequence against that called
from5003 coverage from PCR amplified mtDNA (in 72 individ-
uals). After considering only those sites where the average de-
gree of heteroplasmy was greater than 10% in both datasets
and where the Pearson correlation r2 between 1003 and 5003
coverage data was higher than 0.9, six sites remained suitable
for association testing (Supplemental Experimental Procedures;
Table S4). One site was significantly associated with mtDNA
levels (position = 513, p value = 3.27 3 109, effect = 0.279,
variance explained = 0.48%). This site is known to harbor heter-
oplasmy and is located in the D-loop regulatory region, but it has
not been identified as a transcription factor binding site [14],
DNase1-protected site, or splice cut site [16]. We also examined
whether the use of down-sampled data might influence our re-
sults. Performing the same analysis on the entire dataset led to
a decrease in significance of the site at 513 (p value 7.65 3
105, effect =0.188, variance explained = 0.15%). The associ-
ation results for the six heteroplasmic sites with the amount of
mtDNA are shown in Table 2.
We explored the relationship between MDD, genetic control
over the amount of mtDNA, and heteroplasmy. We asked firstCurrent Biowhether genetic control over the amount of mtDNA was different
in cases of MDD and controls. When we included MDD as a co-
variate in the GWAS for amount of mtDNA, peaks at TFAM and
CDK6 remained significantly associated with amount of mtDNA
(p value = 6.96 3 1028, 6.63 3 1016 for rs11006126 and
rs445, respectively), and there were no further peaks found. Fig-
ure S1 shows the Manhattan and quantile-quantile plots of this
GWAS. Testing specifically for an interaction with MDD, we
found no region of the genome exceeded genome-wide signifi-
cance. Interaction p values at the two SNPs that were associated
with the amount of mtDNA are 0.70 at rs11006126 and 0.71 at
rs445. Therefore, our data indicate effects at both loci on the
amount of mtDNA are independent of MDD disease status.
Even though MDD is a strong predictor of the amount of
mtDNA [6], and even though the genetic correlation between
amount of mtDNA and MDD computed from genome-wide
SNPs [8, 17] was 46.7% (SE = 14.3%, p value = 3.53 3 104),
SNPs at TFAM and CDK6 were not associated with MDD
(p value = 0.70 for rs11006126, p value = 0.53 for rs445, from a
linear mixed model). Furthermore, no homoplasmic variant was
associated with MDD in our cohort, nor were any of the six het-
eroplasmic sites with verified degrees of heteroplasmy associ-
ated with MDD (Table S5).
Finally, we asked whether the total amount of heteroplasmy
differed between MDD cases and controls. Using the 26 hetero-
plasmic sites called from low-coverage sequencing on all
samples, we computed a heteroplasmic load per sample
(number of heteroplasmic sites per sample) in the down-
sampled data and found it to be significantly higher in MDD
cases (mean fold increase = 1.05, p value = 1.40 3 104). We
performed the same analysis on the high-coverage sequencinglogy 25, 3170–3177, December 21, 2015 ª2015 The Authors 3173
Table 2. Association between the Degree of Heteroplasmy at Four Heteroplasmic Sites with the Amount of mtDNA
Marker Ref. Alt. Freq. Annotation Gene
Association with mtDNA
Effect Var. Exp. p Log p
MT146 T C 0.005 upstream RNR1,tRNA-Phe 0.650 0.001 6.14E-01 0.212
MT451 A I 0.002 regulatory NA 0.501 0.000 4.76E-01 0.322
MT513 G I 0.416 regulatory NA 0.279 0.005 3.27E-09 8.485
MT5894 A I 0.017 regulatory NA 0.617 0.001 3.36E-01 0.473
MT15939 C I 0.014 regulatory NA 0.005 0.000 9.45E-01 0.025
MT16129 G A 0.020 upstream;downstream tRNA-Pro;CYTB,tRNA-Thr 0.167 0.000 6.36E-01 0.197
This table shows the association between degree of heteroplasmy at four heteroplasmic sites in themtDNA and amount of mtDNA quantified from low-
coverage sequencing in 10,442 samples fromCONVERGE. The first four columns show the position of the heteroplasmic site in mtDNA (Marker), refer-
ence allele in the human mitochondrial genome reference NC_012920.1 (Ref.), the alternative allele (Alt.) for which the heteroplasmy is detected, and
the frequency of occurrence of this heteroplasmy in the cohort (Freq.). An ‘‘I’’ in the Alt. column means the heteroplasmy is for an insertion or deletion
mutation. The next two columns show characteristics of the four heteroplasmic sites: annotation of variant function (Annotation) and nearest gene
(Gene). The final four columns show the results of association testing between degree of heteroplasmy at each site with amount of mtDNA by linear
regression: direction of effect (Effect) from linear regression, variance of amount of mtDNA explained by the site heteroplasmy (Var. Exp.) from differ-
ence in residual sum of squares in ANOVA between the model with and without degree of heteroplasmy as the test term in linear regression, p value of
association (p) between degree of heteroplasmy and amount of mtDNA, and –log10 of the p value (Log p). One site position 513 is significantly asso-
ciated with amount of mtDNA, with a positive effect, and it lies in the D-loop regulatory region in the mtDNA. See also Table S5.of long-range PCR on mtDNA from 72 samples and confirmed
our finding: cases of MDD had higher levels of heteroplasmy
(p value = 0.032).
The human data alone cannot determine whether the in-
creased rates of heteroplasmy are cause or consequence of
the stress-related illness; therefore, we turned to an experi-
mental system in which we explored the consequences of expo-
sure to stress in mice [6]. We performed long-range PCR of the
mtDNA from 12 female C57BL/6J mice, six of which were sub-
ject to a 4-week chronic stress regimen, while six were kept in
standard laboratory conditions for the same 4-week period.
Stressed mice had higher amounts of mtDNA than controls
(mean fold increase = 2.16, p value = 0.004, Figure 3A). We iden-
tified 76 heteroplasmic variants in thesemice in the samewaywe
did the 72 CONVERGE samples, down-sampling each site to
500 reads. Stressed mice had higher levels of heteroplasmy
(mean fold increase = 1.46, p value = 0.029, Figure 3B).
DISCUSSION
Our study identifies two nuclear genomic loci that contribute
to amount of mtDNA and one position in the mitochondrial
genome. Of the nuclear loci, TFAM is already known to be
essential for mtDNA transcription and is a regulator of
mtDNA copy number, replication, and repair [4, 18]. CDK6,
by contrast, has not previously been implicated in mitochon-
drial function (unlike CDK5, which also associates with D-type
cyclins [19]).
The association between the amount of mtDNA and a variant
in a regulatory region of the mitochondrial genome can be inter-
preted in two ways: the frequency of the variant may increase as
a consequence of increased turnover of mtDNA, or it may itself
affect the replication of the mtDNA molecule. While we cannot
currently distinguish between these two alternatives, it is worth
noting that the association may represent an example of adap-
tive mutation [20], in which genetic variation occurs in response
to the environment, rather than independently of it. Instances of
environmentally induced mutations have been documented in3174 Current Biology 25, 3170–3177, December 21, 2015 ª2015 Thebacteria [21], and a similar process may affect the mitochondrial
genome.
Intriguingly, none of the variants, either in the nuclear or mito-
chondrial genome, contribute to the risk of MDD, despite the fact
that the genetic correlation between MDD and the amount of
mtDNA is 0.46. The latter finding argues that loci exist that exert
pleiotropic influence on both risk to depression and mitochon-
drial function.
Our findings raise questions about how cells manage the turn-
over of mtDNA sequence. The increase in heteroplasmy we
observe in cases of MDD, likely due to stress (as the mouse
experiment implies), might appear detrimental to cell survival,
given themutational burden heteroplasmywill impose. However,
it should be borne in mind that mtDNA mutations need not dam-
age an organism: indeed, mutations in genes with mitochondrial
function can increase lifespan [22]. Intriguingly, overexpression
of TFAM also leads to increased cell survival, with improvements
at an organ and system level [2, 23–26]. These effects are due in
part, if not entirely, to increases in the number of mitochondria
[27], suggesting concerted action between alterations in copy
number and sequence to protect cells, and organisms, exposed
to stress.
EXPERIMENTAL PROCEDURES
Sample Collection, Sequencing, and Genotyping
Adescription of the sample collection, the low-pass DNA sequencing and gen-
otyping of the nuclear genome is given in [7]. DNA was extracted from saliva
samples. mtDNA sequence was processed as described below. All reads
mapping to the human mitochondrial genome NC_012920.1 were extracted
from the whole genome BAM files mapped to GRCh37.p5 using Samtools
(v.0.1.18) [28]. The mitochondrial reads extracted were then converted to the
FASTQ format using Picard (v.1.108, http://broadinstitute.github.io/picard/)
and mapped to a combined reference containing 894 complete bacterial ge-
nomes, 2,024 complete bacterial chromosomes, 154 draft assemblies, and
4,373 complete plasmids sequences (in total 7,390 unique bacterial DNA
sequences) available on NCBI using BWA (v.0.5.6) [29]. All reads mapping to
bacterial DNA sequences were filtered out using FLAGs attached to each
read in the BAM format. Unmapped reads, unpaired reads, reads that did
not pass quality control, and reads that may be PCR or optical duplicatesAuthors
A B Figure 3. Heteroplasmy Counts in
Stressed and Control Mice
The figures shows (A) boxplot of the amount
of mtDNA quantified from high-coverage
sequencing of long-range PCR of mtDNA from
liver samples (controlled for starting mass of
genomic DNA extracted from mice livers then
quantile normalized among all 12 mice) of six
female mid-age C56BL/6J mice exposed to a
4-week chronic stress protocol (shown in red),
compared to that from the liver samples of six
female, mid-age C56BL/6J control mice (shown
in blue). Normalized amount of mtDNA from liver
samples of six mice was significantly higher than
that in non-stressed control mice mean (fold in-
crease = 2.16, p value = 0.0040), and (B) the
number of heteroplasmic variant sites found in
high-coverage sequencing of long-range PCR of
mtDNA (down-sampled to equal coverage of 500
reads per site) from liver samples of six female
mid-age C56BL/6J mice exposed to a 4-week
chronic stress protocol, compared to that
from the liver samples of six female, mid-age
C56BL/6J control mice, where each point repre-
sents one mouse; stressed mice had significantly
higher number of heteroplasmic variants in
mtDNA per sample (mean fold increase = 1.46,
p value = 0.029).were excluded. These procedures filtered out any reads mapping to non-hu-
man sequence, as well as removing poor quality reads.
Estimation of mtDNA Copy Number
We obtained high-coverage mtDNA sequencing reads (102.33) from paired-
end low-coverage (1.73) whole-genome sequencing data of 10,560
CONVERGE study samples. To quantify mtDNA levels and avoid biases due
to potential mapping of similar sequences in nuclear copies of mtDNA
(NUMTs) [13] or contaminant bacterial sequences onto the mitochondrial
reference, we calculated the mean coverage of mtDNA read pairs per
100 bp along the mtDNA reference both before and after filtering those
reads that map uniquely to the human mitochondrial genome reference
NC_012920.1 with a high mapping quality filter of 50 (Phred-scale). The inter-
vals with high discrepancies between filtered and unfiltered mappings are
those enriched in mtDNA sequences similar to NUMTs or other contaminants,
and they are excluded from the calculation of mean mtDNA read depth,
which is then controlled for nuclear DNA (chr20) sequencing coverage,
sequencing batch, and sample age before transforming to normality by quan-
tile-normalization.
Estimation of Whole-Genome and Single-Gene SNP-Based
Heritability for Amount of mtDNA
LinkageDisequilibriumAdjustedKinship (LDAK, v.4.9) [8] was used to estimate
local linkage disequilibrium (LD) by calculation of local pairwise correlations
between SNPs and generating weightings of each SNP in the calculation of
a genetic relatedness matrix (GRM) adjusted for local LD between all samples.
A GRM was generated using all 6,242,619 SNPs from all chromosomes, on
which restrictedmaximum likelihood (REML) is used for estimating the propor-
tions of variance explained by all SNPs in the GRMs for amount of mtDNA.
Gene-based heritability was obtained for all genes using LDAK. Gene bound-
aries were obtained from RefSeq for human reference genome Build 37, hg19
(February 2009).
Nuclear DNA GWAS Using a Linear Mixed Model
We performed GWAS on mtDNA levels one chromosome at a time, with
a mixed-linear model including a genetic relationship matrix (GRM) con-
structed from SNPs other than those on the chromosome being studied,Current Bioand top five PCs from eigen decomposition of the GRM as covariates. This
method is implemented in Factored Spectrally Transformed Linear Mixed
Models (FastLMM v.2.06.20130802) [30]. For GWAS on mtDNA levels
controlling for MDD status, the same linear mixed model was used with input
of MDD status of all samples as a binary covariate. Manhattan plots and
quantile-quantile plots of the log10 of p values of the GWAS were generated
with custom code in R. Genomic-control inflation factor lambda was calcu-
lated in R.
Replication Sample
A measure of mtDNA was obtained from the Avon Longitudinal Study of Par-
ents and Children (ALSPAC) [10] (http://www.bristol.ac.uk/alspac/) whole-
genome-sequencing cohort [11], and normalized for the amount of nuclear
DNA (using chromosome 20 read depth). Genotype dosages for two SNPs
(rs445 and rs1100612) were obtained from ALSPAC and analyzed for associ-
ation with mtDNA by linear regression, and the joint sample (CONVERGE and
ALSPAC) analyzed with a fixed-effects meta-analysis. ALSPAC data are avail-
able through a searchable data dictionary (http://www.bris.ac.uk/alspac/
researchers/data-access/data-dictionary/). Ethical approval for the study
was obtained from the ALSPAC Ethics and Law Committee and the Local
Research Ethics Committees.
Estimation of Genetic Correlation between Amount of mtDNA
and MDD
Genetic correlation between amount of mtDNA andMDD was estimated using
bivariate REML in GCTA [17] (v.1.24.4), where the input GRM was the same
GRM used for estimating whole-genome SNP-based heritability, generated
with LDAK using all 6,242,619 SNPs from all chromosomes. The binary MDD
status was converted to liability scale with a population prevalence of disease
of 8% for this estimation.
Calling of Homoplasmic and Heteroplasmic Variants in the mtDNA
from Low-Coverage Sequencing
We obtained total and per allele read depth for only sequencing reads that
map uniquely to the mitochondria using Samtools mpileup (v.0.1.18) [28].
Filtering criteria also include a base quality threshold of 20 (Phred-scaled)
for bases and mapping quality of 50 (Phred-scaled) and no more than fourlogy 25, 3170–3177, December 21, 2015 ª2015 The Authors 3175
mismatches to the reference for reads. To filter out potential mismappings
due to nucleotide homopolymer runs on the mtDNA, we only interrogated
14,796 out of 16,569 sites in the mtDNA sequence, masking out 1,773 sites
in the mtDNA for being in or beside homopolymer runs of four or more
nucleotides.
For calling of homoplasmic variants, we first discarded any site in themtDNA
in any sample that was covered by fewer than ten sequencing reads, and any
site that is discarded by this criterion inmore than 10%of the samples. A site is
considered a homoplasmic variation in the cohort if there were two alleles pre-
sent in the cohort, and each of themwas supported bymore than 90%of reads
in more than 0.1% of the cohort (ten samples among 10,442). We identified
1,031 homoplasmic sites with the above criteria.
For calling of heteroplasmic variants, sequencing coverage at each site in
the mtDNA from each sample was independently and randomly down-
sampled to 50 reads; sites in any sample covered by fewer than 50 reads
were discarded from the analysis, and sites with more than 10% of the sam-
ples discarded by the above criterion were then completely disregarded for
further analysis due to lack of evidence. A site was considered potentially
heteroplasmic if there was presence of two or more alleles each supported
by more than or equal to two reads (4%, out of 50 reads). We then calculated
both (1) the degree of heteroplasmy per potential heteroplasmic site in a
single individual and (2) the frequency of occurrence of heteroplasmy at a
each site in the population. We only considered those sites where more
than 0.1% (ten samples among 10,442) of the sample show any degree of
heteroplasmy.
Association Testing with mtDNA Variants Using Linear Regression
Model
Testing of association between mtDNA levels and homoplasmic and hetero-
plasmic variants in the mtDNA above 0.1% in occurrence in CONVERGE
were carried out with a linear regression model using a custom script in
R. Homoplasmic mtDNA variation among samples was coded as a binary
measure representing the reference and alternative alleles relative to the hu-
man mitochondrial genome reference NC_012920.1. Heteroplasmic mtDNA
variation among samples was coded as residuals from a linear regression of
the number of reads supporting the alternative allele with site-specific read
depth, whole-genome sequencing coverage and sequencing batch included
as covariates. Significance thresholds were determined with a Bonferroni
correction for multiple testing on a p value threshold of 0.05.
Long-Range PCR on mtDNA and High-Coverage Sequencing of PCR
Product
For long-range PCR on 72 human DNA samples from CONVERGE, we de-
signed a pair of primers on D-loop sequences on the mtDNA that did not
show sequence similarity with nuclear DNA (forward primer: 50-TGAGGC
CAAATATCATTCTGAGGGGC-30; reverse primer: 50-TTTCATCATGCGGA
GATGTTGGATGG-30 ) for the mtDNA. Long-range PCR using these primers
covered the whole of the 16,569 bp of the mitochondrial genome. We per-
formed the PCR on 72 samples with thermal cycling conditions as follows:
one 1-min cycle at 98C, 30 cycles of 10 s at 98C, and then 8 min 15 s at
72C, one 10-min cycle at 72C, and then storing PCR products at 4C.
For long-range PCR on 12 mouse DNA samples, we designed a pair of
primers on D-loop sequences on the mtDNA that did not show sequence sim-
ilarity with nuclear DNA (forward primer: 50- CCCAGCTACTACCATCATTC
AAGT-30; reverse primer: 50- GAGAGATTTTATGGGTGTAATGCGG-30) for
the mtDNA. Long-range PCR using these primers covered the whole of the
16,229 bp of themitochondrial genome.We performed the PCRon 72 samples
with thermal cycling conditions as follows: one 1-min cycle at 98C, 30 cycles
of 10 s at 98C, 30 s at 68C, and then 8 min 15 s at 72C, one 10-min cycle
at 72C, and then storing PCR products at 4C.
PCR mix for both reactions contain 5 ml 5 3 GC buffer, 1 ml 10 mM dNTPs,
5 ml Primer cocktail, 0.5 ml 2 U/ml High-Fidelity DNA Polymerase, 100 ng
sample DNA.
The PCR products were then sheared to approximately 500-bp fragments
and used to construct libraries for sequencing using Illumina Hiseq4000,
yielding 100-bp paired-end reads with average per site read depth of 1,757
for human samples and 1,368 for mouse samples. Sequencing products
from this process contains only mtDNA.3176 Current Biology 25, 3170–3177, December 21, 2015 ª2015 TheCalling of Heteroplasmic Variants in Human andMouse mtDNA from
High-Coverage Sequencing of Long-Range PCR Product
Sequencing reads from human samples were mapped to the human mtDNA
reference NC_012920.1 using BWA (v.0.5.6) [29] and Samtools (v.0.1.18)
[28], while sequencing reads from mice were mapped using the same soft-
ware to mtDNA reference sequence in mouse reference genome build
GRCm38. We obtained total and per allele read depth for sequencing
reads that mapped to the human and mouse mitochondria using Samtools
mpileup (v.0.1.18) [28]. Filtering criteria also include a base quality threshold
of 20 (Phred-scaled) for bases, and mapping quality of 50 (Phred-scaled)
and no more than four mismatches to the reference for reads. To filter out
potential mismappings due to nucleotide homopolymer runs on the mtDNA,
we only interrogated 14,796 out of 16,569 sites in the human mtDNA
sequence and 14,717 out of 16,229 site in the mouse mtDNA sequence,
masking out 1,773 and 1,512 sites in the mtDNA for being in or beside
homopolymer runs of four or more nucleotides. Sequencing coverage at
each site was then independently and randomly down-sampled to 500
reads; sites in any sample covered by fewer than 500 reads were discarded
from the analysis, and sites with more than a third of the human and mice
samples discarded, respectively, were then completely disregarded for
further analysis due to lack of evidence. A site was considered heteroplasmic
in a sample if there was presence of two or more alleles each supported by
more than or equal to 1% of sequencing reads (five reads out of 500 reads).
We then calculated the degree of heteroplasmy per sample per heteroplas-
mic site.
SUPPLEMENTAL INFORMATION
Supplemental Information includes Supplemental Experimental Procedures,
one figure, and five tables and can be found with this article online at http://
dx.doi.org/10.1016/j.cub.2015.10.065.
AUTHOR CONTRIBUTIONS
Conceptualization, N.C. and J.F.; Methodology, N.C., S.C., T.M., G.J.H., and
J.F.; Validation, N.C., J.L., C.L., X.Z., L.L., Y.C., J.H., and Q.L.; Investigation,
N.C., Y.L., S.C., T.M., W.C., and J.F.; Writing – Original Draft, N.C. and J.F;
Writing – Review & Editing, N.C., R.M. and J.F.; Funding Acquisition, K.S.K
and J.F., Resources, G.J.H., K.S.K., and J.F.; Supervision, J.F.
ACKNOWLEDGMENTS
This work was funded by the Wellcome Trust (WT090532/Z/09/Z, WT083573/
Z/07/Z, WT089269/Z/09/Z) and by NIH grant MH-100549. All authors are part
of the CONVERGE consortium (China, Oxford, and VCU Experimental
Research on Genetic Epidemiology) and gratefully acknowledge the support
of all partners in hospitals across China. N.C. is supported by the Agency of
Science, Technology and Research (A*STAR) Graduate Academy. T.M. is
supported by the Long-term Fellowship from the Human Frontier Science
Program. We are extremely grateful to all the families who took part in this
study, the midwives for their help in recruiting them, and the whole ALSPAC
team, which includes interviewers, computer and laboratory technicians, cler-
ical workers, research scientists, volunteers, managers, receptionists, and
nurses. The UK Medical Research Council and the Wellcome Trust (Grant
ref: 102215/2/13/2) and the University of Bristol provide core support for
ALSPAC.
Received: August 6, 2015
Revised: October 7, 2015
Accepted: October 28, 2015
Published: December 10, 2015
REFERENCES
1. Robin, E.D., and Wong, R. (1988). Mitochondrial DNA molecules and vir-
tual number of mitochondria per cell in mammalian cells. J. Cell. Physiol.
136, 507–513.Authors
2. Clay Montier, L.L., Deng, J.J., and Bai, Y. (2009). Number matters: control
of mammalian mitochondrial DNA copy number. J. Genet. Genomics 36,
125–131.
3. Tang, Y., Schon, E.A., Wilichowski, E., Vazquez-Memije, M.E., Davidson,
E., and King, M.P. (2000). Rearrangements of human mitochondrial DNA
(mtDNA): new insights into the regulation of mtDNA copy number and
gene expression. Mol. Biol. Cell 11, 1471–1485.
4. Campbell, C.T., Kolesar, J.E., and Kaufman, B.A. (2012). Mitochondrial
transcription factor A regulates mitochondrial transcription initiation,
DNA packaging, and genome copy number. Biochim. Biophys. Acta
1819, 921–929.
5. Johnston, I.G., Gaal, B., Neves, R.P., Enver, T., Iborra, F.J., and Jones,
N.S. (2012). Mitochondrial variability as a source of extrinsic cellular noise.
PLoS Comput. Biol. 8, e1002416.
6. Cai, N., Chang, S., Li, Y., Li, Q., Hu, J., Liang, J., Song, L., Kretzschmar,
W., Gan, X., Nicod, J., et al. (2015). Molecular signatures of major depres-
sion. Curr. Biol. 25, 1146–1156.
7. CONVERGE Consortium (2015). Sparse whole-genome sequencing iden-
tifies two loci for major depressive disorder. Nature 523, 588–591.
8. Speed, D., Hemani, G., Johnson, M.R., and Balding, D.J. (2012). Improved
heritability estimation from genome-wide SNPs. Am. J. Hum. Genet. 91,
1011–1021.
9. Pruim, R.J., Welch, R.P., Sanna, S., Teslovich, T.M., Chines, P.S., Gliedt,
T.P., Boehnke, M., Abecasis, G.R., and Willer, C.J. (2010). LocusZoom:
regional visualization of genome-wide association scan results.
Bioinformatics 26, 2336–2337.
10. Boyd, A., Golding, J., Macleod, J., Lawlor, D.A., Fraser, A., Henderson, J.,
Molloy, L., Ness, A., Ring, S., and Davey Smith, G. (2013). Cohort Profile:
the ‘children of the 90s’–the index offspring of the Avon Longitudinal Study
of Parents and Children. Int. J. Epidemiol. 42, 111–127.
11. Walter, K., Min, J.L., Huang, J., Crooks, L., Memari, Y., McCarthy, S.,
Perry, J.R., Xu, C., Futema, M., Lawson, D., et al.; UK10K Consortium
(2015). The UK10K project identifies rare variants in health and disease.
Nature 526, 82–90.
12. Ding, J., Sidore, C., Butler, T.J., Wing, M.K., Qian, Y., Meirelles, O.,
Busonero, F., Tsoi, L.C., Maschio, A., Angius, A., et al. (2015). Assessing
Mitochondrial DNA Variation and Copy Number in Lymphocytes of
2,000 Sardinians Using Tailored Sequencing Analysis Tools. PLoS
Genet. 11, e1005306.
13. Hazkani-Covo, E., Zeller, R.M., and Martin, W. (2010). Molecular polter-
geists: mitochondrial DNA copies (numts) in sequenced nuclear genomes.
PLoS Genet. 6, e1000834.
14. Marinov, G.K., Wang, Y.E., Chan, D., and Wold, B.J. (2014). Evidence for
site-specific occupancy of the mitochondrial genome by nuclear tran-
scription factors. PLoS ONE 9, e84713.
15. Abecasis, G.R., Auton, A., Brooks, L.D., DePristo, M.A., Durbin, R.M.,
Handsaker, R.E., Kang, H.M., Marth, G.T., and McVean, G.A.; 1000
Genomes Project Consortium (2012). An integrated map of genetic varia-
tion from 1,092 human genomes. Nature 491, 56–65.
16. Mercer, T.R., Neph,S., Dinger,M.E., Crawford, J., Smith,M.A., Shearwood,
A.M., Haugen, E., Bracken, C.P., Rackham, O., Stamatoyannopoulos, J.A.,
et al. (2011). The human mitochondrial transcriptome. Cell 146, 645–658.Current Bio17. Lee, S.H., Yang, J., Goddard, M.E., Visscher, P.M., andWray, N.R. (2012).
Estimation of pleiotropy between complex diseases using single-
nucleotide polymorphism-derived genomic relationships and restricted
maximum likelihood. Bioinformatics 28, 2540–2542.
18. Ekstrand, M.I., Falkenberg, M., Rantanen, A., Park, C.B., Gaspari, M.,
Hultenby, K., Rustin, P., Gustafsson, C.M., and Larsson, N.G. (2004).
Mitochondrial transcription factor A regulates mtDNA copy number in
mammals. Hum. Mol. Genet. 13, 935–944.
19. Meuer, K., Suppanz, I.E., Lingor, P., Planchamp, V., Go¨ricke, B., Fichtner,
L., Braus, G.H., Dietz, G.P., Jakobs, S., Ba¨hr, M., and Weishaupt, J.H.
(2007). Cyclin-dependent kinase 5 is an upstream regulator of mitochon-
drial fission during neuronal apoptosis. Cell Death Differ. 14, 651–661.
20. Rosenberg, S.M. (2001). Evolving responsively: adaptive mutation. Nat.
Rev. Genet. 2, 504–515.
21. Hastings, P.J., Bull, H.J., Klump, J.R., and Rosenberg, S.M. (2000).
Adaptive amplification: an inducible chromosomal instability mechanism.
Cell 103, 723–731.
22. Lee, S.S., Lee, R.Y., Fraser, A.G., Kamath, R.S., Ahringer, J., and Ruvkun,
G. (2003). A systematic RNAi screen identifies a critical role for mitochon-
dria in C. elegans longevity. Nat. Genet. 33, 40–48.
23. Ikeuchi, M., Matsusaka, H., Kang, D., Matsushima, S., Ide, T., Kubota, T.,
Fujiwara, T., Hamasaki, N., Takeshita, A., Sunagawa, K., and Tsutsui, H.
(2005). Overexpression of mitochondrial transcription factor a ameliorates
mitochondrial deficiencies and cardiac failure after myocardial infarction.
Circulation 112, 683–690.
24. Gauthier, B.R., Wiederkehr, A., Baquie´, M., Dai, C., Powers, A.C., Kerr-
Conte, J., Pattou, F., MacDonald, R.J., Ferrer, J., and Wollheim, C.B.
(2009). PDX1 deficiency causes mitochondrial dysfunction and defective
insulin secretion through TFAM suppression. Cell Metab. 10, 110–118.
25. Hayashi, Y., Yoshida, M., Yamato, M., Ide, T., Wu, Z., Ochi-Shindou, M.,
Kanki, T., Kang, D., Sunagawa, K., Tsutsui, H., and Nakanishi, H. (2008).
Reverse of age-dependent memory impairment and mitochondrial DNA
damage in microglia by an overexpression of human mitochondrial tran-
scription factor a in mice. J. Neurosci. 28, 8624–8634.
26. Piao, Y., Kim, H.G., Oh, M.S., and Pak, Y.K. (2012). Overexpression of
TFAM, NRF-1 and myr-AKT protects the MPP(+)-induced mitochondrial
dysfunctions in neuronal cells. Biochim. Biophys. Acta 1820, 577–585.
27. Suarez, J., Hu, Y., Makino, A., Fricovsky, E., Wang, H., and Dillmann, W.H.
(2008). Alterations inmitochondrial function and cytosolic calcium induced
by hyperglycemia are restored by mitochondrial transcription factor A in
cardiomyocytes. Am. J. Physiol. Cell Physiol. 295, C1561–C1568.
28. Li, H., Handsaker, B., Wysoker, A., Fennell, T., Ruan, J., Homer, N., Marth,
G., Abecasis, G., and Durbin, R.; 1000 Genome Project Data Processing
Subgroup (2009). The Sequence Alignment/Map format and SAMtools.
Bioinformatics 25, 2078–2079.
29. Li, H., and Durbin, R. (2009). Fast and accurate short read alignment with
Burrows-Wheeler transform. Bioinformatics 25, 1754–1760.
30. Listgarten, J., Lippert, C., Kadie, C.M., Davidson, R.I., Eskin, E., and
Heckerman, D. (2012). Improved linear mixed models for genome-wide
association studies. Nat. Methods 9, 525–526.logy 25, 3170–3177, December 21, 2015 ª2015 The Authors 3177
